Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans

Publication date: Available online 13 November 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Yamin Gao, H.M. Adnan Hameed, Yang Liu, Lingmin Guo, Cuiting Fang, Xirong Tian, Zhiyong Liu, Shuai Wang, Zhili Lu, Md Mahmudul Islam, Tianyu Zhang
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research